Commentary

The Midwest had 11 universities in the top 50 institutions winning NIH funding during 2005, including 20th ranked Wisconsin, according to Yer Biotech Blues columnist Michael Rosen. That's pretty impressive considering that NIH funding has been increasingly hard to come by, and it's a key...

James Barr III, the retiring president and CEO of TDS Telecom, believes the next 10 years in the telecommunication industry will be even more eventful than the past decade. As Barr passes the torch to the next generation, he recounts a few developments that were...

If you leave politics up to the people, what happens? A focus on the bread-and-butter issues that matter to them, writes Inside Wisconsin columnist Tom Still. A co-founder of the We The People/Wisconsin project, in which citizens had a chance to shape the questions put...

So-called feature companies, derided by some because they present features rather than products at various conferences, deserve a more serious look from investors, writes DEMO Letter columnist Chris Shipley. Many entrepreneurial companies have presented features that went on to capture the market as products, but...

So what's in a business name? Well, a great deal, according to columnist Joe Boucher and fellow business attorney Brian F. Bates. In this Web era, that's especially true when selecting a domain name, as they explain in the latest edition of Early Stage. Even...

Wisconsin has many economic assets, but it still may not be able to compete with the more nimble and more moneyed east and west coasts. In this latest installment of WTN's Visions Series, Baird CEO Paul Purcell recommends nixing intra- and inter-state rivalries as he...

The promotional aspects of online video have not been lost on the Smirnoff Vodkas and the Nestles (Butterfinger chocolate bars) of the world. These are among the companies that have successfully incorporated online video into their advertising programs. According to Buzz Networks columnist Paul Gibler,...

If you're like a lot of technology and life-science executives, you wonder where your next venture round will come from, and who is competing for those same dollars. If you're not familiar with investors, Private Placements columnist Matt Storms suggests you consider intermediaries known as...

The beta test, once used only to test and prepare products for the "prime time" of market competition, is cynically being used as a mechanism to woo investors and lock out competitors, according columnist Chris Shipley. In this edition of DEMO Letter, Shipley calls out...

The obviousness of inventions is an issue in the challenge to stem cell patents held by the Wisconsin Alumni Research Foundation, and it's the subject of a case now before the United States Supreme Court. At stake, according to Madison attorney and Guest Columnist Chris...